MRVI — Maravai Lifesciences Holdings Share News
0.000.00%
- $1.84bn
- $2.09bn
- $185.74m
Brief: Trilink Biotechnologies And Lonza Enter Non-Exclusive License And Supply Agreement For Cleancap MRNA Capping Technology
U.S. STOCKS ON THE MOVE-Hyatt Hotels, Morningstar Inc, SunPower Corp
Maravai LifeSciences soars on surprise Q4 profit
U.S. STOCKS ON THE MOVE-Universal Insurance, Rocket Companies, Legend Biotech
U.S. STOCKS ON THE MOVE-Carvana, Plug Power, Live Nation
Maravai LifeSciences rises on surprise Q4 profit
Maravai LifeSciences Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Maravai LifeSciences Q4 Revenue USD 74.141 Million
Maravai LifeSciences rallies after BofA upgrades to "buy"
Maravai slides to all-time low on third consecutive 2023 forecast cut
Brief: Maravai LifeSciences Outlook FY Revenue USD 275-285 Million
Maravai LifeSciences Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: Maravai Lifesciences Holdings Inc- Targeting $700M In Revenue And > 40% Adjusted EBITDA In 2028
U.S. RESEARCH ROUNDUP-Intuit, Pioneer Natural Resources, Salesforce
U.S. RESEARCH ROUNDUP-Alteryx, Axsome Therapeutics, Inogen
Maravai LifeSciences Holdings Inc reports results for the quarter ended in June - Earnings Summary
Biotech firm Maravai LifeSciences falls on Q2 revenue slump
Brief: Maravai LifeSciences Outlook FY Revenue USD 300-325 Million
Maravai LifeSciences Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview